Week 4 viral response to peginterferon and ribavirin: how should it be used in combination with a baseline predictive factor?
Hidenori
H
Toyoda
Takashi
T
Kumada
Yoshiaki
Y
Katano
Hidemi
H
Goto
D005260:Female; D006526:Hepatitis C / Q000188:drug therapy*; D006801:Humans; D016898:Interferon-alpha / Q000008:administration & dosage*; D008297:Male; D011092:Polyethylene Glycols / Q000008:administration & dosage*; D012254:Ribavirin / Q000008:administration & dosage*
D016898:Interferon-alpha; D011092:Polyethylene Glycols; D012254:Ribavirin